John Paul von Benecke

Biocompatibles International Ltd. is a leading medical technology company in the field of drug device combination products with an Oncology products division and a Licensing division. In oncology, it has Bead products and BrachySciences and in Licensing, it has two components, CellMed and PC Licensing. It's products that will improve patient outcomes in the treatment of cardiovascular disease, cancer and benign tumours. Biocompatibles International was founded by Dennis Chapman in 1984 and is headquartered in Farnham, UK.

ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK.

Part of Abbott Laboratories, Abbott Laboratories Ltd. is a British company that manufactures, develops and sells pharmaceutical and nutritional products. The company is based in Maidenhead, UK and was founded in 1937.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Creavo Medical Technologies Ltd. manufactures medical imaging devices for chest pain. It focuses on the utilization of advanced quantum principles in the rapid detection of potentially life threatening medical conditions in acute medical settings. Its flagship product, Quantum Vitalscan, is a battery powered and portable medical device that can be used in a routine and acute hospital setting. The company is headquartered in Coventry, the United Kingdom.

Cellnovo Group SA was a medical technology company, which specialized in diabetes. The company developed and marketed the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. It products portfolio included system, switch, pump therapy, and patient stories. The company was founded by Julian Shapley on December 15, 2014 and was headquartered in Paris, France.